GSK is one of only 25 US companies currently accredited by the CEO Cancer Gold Standard
The CEO Cancer Gold Standard is a workplace initiative that combats cancer by focusing on three objectives: risk reduction, early detection and quality care. This aligns closely with GSK’s Triple Message of 1) prevention, 2) intervention in chronic disease, and 3) innovation to improve health.
Announcements
Research & development at GSK
Marathons – R&D's online, multimedia magazine
Recent headlines
[an error occurred while processing this directive]
[an error occurred while processing this directive]
November 18, 2008
Study published in archives of surgery demonstrated benefit of ENTEREG® (alvimopan) in postoperative ileus
November 17, 2008
Smokers drink almost twice as much coffee as nonsmokers, but unaware of impact of caffeine intake when quitting, new survey finds
November 14, 2008
New data shows Lovaza® improves multiple lipid parameters in patients with mixed dyslipidemia beyond effect of statin alone
GSK News Services
Leading the way to make clinical trial data more transparent
Learn about flu treatment
Find health information
Save money on your prescriptions
Join GSK
Updated November 18, 2008
© 2001 - 2008 GlaxoSmithKline - All rights reserved